Cytodyn Inc (CYDY)

[Learning53]

Staggering fact: "Just considering television, 187 commercials for about 70 prescription medications have collectively aired almost half a million times since the start of 2018..."

It was calculated that in 2020, the pharmaceutical industry in the United States spent 6.58 billion U.S. dollars on direct-to-consumer advertising. In the same period of 2019 the pharma sector spent 6.56 billion dollars.

But

Leronlimab is a threat to many drug lines for a few reasons:

1. It is capable of "helping" in a long list of "indications" (diseases, conditions, afflictions, etc.)

2. It is surprisingly safe generally manifesting only minor short term side effects (when they do occur).

3. It is easy to administer and generally consists of a few sub-cutaneous injections.

4. It is NOT controlled by the "brotherhood of Big Pharma" which means it will be in competition with their drug lines, many of which are not as effective and/or have serious potentially life-threatening side effects.

So Big Pharma (BP) is spending a LOT OF MONEY pushing their drugs - they aren't happy about this "newcomer" named Leronlimab. But YOU might like it, because it could end up saving YOUR life...think about it!

That might explain a sort of negative "breeze" you might have noticed, LOL.


IMO